EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Coffee and multiple sclerosis (MS)

Youssef K Ghallab, Omnia S Elassal, Ruth G Mina

Progress in Brain Research · 2024

DOI: 10.1016/bs.pbr.2024.06.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Progress in Brain Research, 2024. Verfasst von Youssef K Ghallab und 2 weiteren Autor:innen. Beteiligte Einrichtung: New Programs, Biotechnology Program, Faculty of Agriculture, Ain Shams University, Hadayek Shoubra, Cairo, Egypt. Electronic address: youssefkhaled@a…. Hauptthemen laut MEDLINE: Coffee, Multiple Sclerosis, Caffeine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple Sclerosis (MS) is a long-term autoimmune disorder affecting the central nervous system, marked by inflammation, demyelination, and neurodegeneration. While the exact cause of MS remains unknown, recent research indicates that environmental factors, particularly diet, may influence the disease's risk and progression. As a result, the potential neuroprotective effects of coffee, one of the most popular beverages worldwide, have garnered significant attention due to its rich content of bioactive compounds. This chapter explores the impact of coffee consumption on patients with Multiple Sclerosis, highlighting how coffee compounds like caffeine, polyphenols, and diterpenes can reduce inflammation and oxidative stress while enhancing neural function. It highlights caffeine's effect in regulating adenosine receptors, specifically A1R and A2AR, which play important roles in neuroinflammation and neuroprotection in MS. The dual role of microglial cells, which promote inflammation while also aiding neuroprotection, is also highlighted concerning caffeine's effects. Furthermore, the potential of A2AR as a therapeutic target in MS and the non-A2AR-dependent neuroprotective benefits of coffee. In this chapter we suggest that the consumption of coffee has no harmful effect on an MS patient and to a larger extent on public health, and informs future research directions and clinical practice, ultimately improving outcomes for individuals living with MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoffeeMultiple SclerosisCaffeineHumansNeuroprotective AgentsAnimals

Stichwörter der Autor:innen

Adenosine receptors (A1R, A2AR)CaffeineCoffeeMultiple sclerosis (MS)NeuroprotectionNeuroprotective effects

Substanzen

CoffeeCaffeineNeuroprotective Agents

Autor:innen und Institutionen

  • New Programs, Biotechnology Program, Faculty of Agriculture, Ain Shams University, Hadayek Shoubra, Cairo, Egypt. Electronic address: youssefkhaled@agr.asu.edu.eg.
  • School of Information Technology and Computer Science, Major of Biomedical Informatics, Nile University, Giza, Egypt.
  • International Euro-Mediterranean Programs, Neuroscience and Biotechnology Program, Faculty of Science, Alexandria University, El-Shatby, Alexandria, Egypt.

Zitieren

APA

Ghallab, Y. K., Elassal, O. S., & Mina, R. G. (2024). Coffee and multiple sclerosis (MS). Progress in Brain Research. https://doi.org/10.1016/bs.pbr.2024.06.009

Vancouver

Ghallab YK, Elassal OS, Mina RG. Coffee and multiple sclerosis (MS). Progress in Brain Research. 2024. doi:10.1016/bs.pbr.2024.06.009

BibTeX
@article{Ghallab2024,
  author = {Ghallab, Youssef K and Elassal, Omnia S and Mina, Ruth G},
  title = {Coffee and multiple sclerosis (MS)},
  journal = {Progress in Brain Research},
  year = {2024},
  doi = {10.1016/bs.pbr.2024.06.009}
}
Kostenlos starten →